Small sized trials with big needs.
在罕见病研究中，未满足的患者需求促进了新的科学发现。但是，对于小而难以找到的患者人群，每个研究都需要一个经验丰富的团队，他们知道如何驾驶细微差别。并解决未知数。因此，您可以为患者及其家人带来新的治疗方法。
迎接挑战
Your work brings hope to the families of more than 350 million people living with one of 7,000 rare diseases. With so few approved treatments, you can make a real difference.
But you face immense challenges in finding dispersed patients, identifying meaningful endpoints, creating novel study designs, and executing everything flawlessly.
Backed by the exceptional approach and resources of IQVIA, the leading Human Data Science Company™, our unified team of experts is ready to help.
Decentralized Trials tailored to rare diseases
336 études
dans le domaine des maladies rares dans 71 pays depuis 2016访问最新的人类科学和数据科学以加速结果
IQVIA将无与伦比的数据，可操作的见解，先进的技术和深层治疗专业知识用于解决方案王者荣耀kpl外围投注，以加速稀有疾病的结果。通过利用这些集成功能，您可以
- Identify the right sites:Identify sites treating patients for your protocol with IQVIA's proprietary algorithms and real world data analysed by IQVIA's rare disease experts
- Global and expansive reach:Tap into IQVIA's extensive global site and patient advocacy group relationships in rare disease
- 与专家合作：Benefit from rare disease experts who've been there, and delivered; our experts can provide counsel on needs from complex study and protocol designs, to regulatory approval and reimbursement market access
- Improve commercial decisions:IQVIA的高级分析，包括机器学习和预测分析功能，可帮助您从数据中产生新的见解王者荣耀kpl外围投注
- See the impact of new innovations and treatments:Be ahead of the curve in planning for and executing on regenerative medicines and cell and gene therapies
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Access new resources for advanced therapy development, from candidate identification through market authorization.
Richer real world data insights can drive smarter decisions.